点击显示 收起
Industry Responds
In a strongly worded statement released last week, a leading cosmetics trade group questioned the relevance of the study, noting that the importance of anogenital distance is unknown in humans and has only been used previously in animal studies.
"The sensational and alarming conclusions being drawn from this single study are completely speculative and scientifically unwarranted," the Cosmetics, Toiletry, and Fragrance Association statement reads.
"While we are committed to having these new data fully evaluated by both internal and external reproduction experts, we remain convinced of the safety of phthalates in cosmetics. All scientific reviews to date around the world by key scientific experts and governmental agencies have concluded that phthalates are safe for use in cosmetics under the current conditions of use."
In a separate statement, officials with the American Chemistry Council also charge that the study was flawed and "may not stand up under rigid scientific scrutiny."
"The harder the look this paper gets, the more questions it raises," says Marian Stanley, manager of the group's Phthalate Esters Panel. "In all, publication of a preliminary, small study of data whose significance is not known, in a journal that is not independently peer-reviewed, needs to be treated with extreme caution until it can be properly evaluated."
SOURCES: The Endocrine Society's 87th annual meeting, San Diego, June 4-7, 2005. Shanna Swan, PhD, professor of obstetrics and gynecology, University of Rochester Medical Center. Bruce Redmond, MD, University of Minnesota Medical School. Kim Boekelheide, MD, PhD, professor, department of pathology cosmetics, Brown University. Toiletry and Fragrance Association. American Chemistry Council.